Oxidized low-density lipoprotein-induced microparticles promote endothelial monocyte adhesion via intercellular adhesion molecule 1

Am J Physiol Cell Physiol. 2017 Nov 1;313(5):C567-C574. doi: 10.1152/ajpcell.00158.2016. Epub 2017 Aug 16.

Abstract

Oxidized low-density lipoprotein (oxLDL) accumulates early in atherosclerotic lesions and plays an important role in the progressive formation of atherosclerotic plaques. Endothelial derived microparticles (EMPs) form a heterogeneous population of <1-μm particles that shed from endothelial membranes upon activation. While EMPs are shown to be involved in atherosclerotic pathophysiology and progression, there is no report regarding the relationship between oxLDL and EMPs. In this study, we aim to determine the influence of oxLDL on endothelial microparticle release and the subsequent regulation of the endothelial activation. EMPs were collected from the medium of human umbilical vein endothelial cells (HUVECs) treated with oxLDL or PBS as control. We find that oxLDL increases the release of EMPs containing intercellular adhesion molecule 1 (ICAM-1) but not vascular cell adhesion molecule 1 (VCAM-1). Confocal microscopy analysis further demonstrates that these EMPs interact with endothelial cells and increase the expression of ICAM-1 in HUVECs. The fact that injecting oxLDL-induced EMPs via the tail vein of ICR mice augments ICAM-1 expression on aortic endothelial cells confirms our results in vivo. Finally, oxLDL-induced EMPs from HUVECs increase the adhesion of monocytes to endothelial cells as determined by the adhesion assay. Our study suggests that oxLDL may augment the release of EMPs harboring increased levels of ICAM-1 that can be transferred to endothelial cells elsewhere. This leads to increased monocyte recruitment in other regions where oxLDL accumulation was initially more limited. EMPs may therefore serve as the mediator that propagates oxLDL-induced endothelial inflammation.

Keywords: EMPs; ICAM-1; VCAM-1; endothelial inflammation; oxLDL.

MeSH terms

  • Animals
  • Atherosclerosis / metabolism
  • Cell Adhesion / drug effects
  • Cell-Derived Microparticles / drug effects*
  • Human Umbilical Vein Endothelial Cells / drug effects
  • Human Umbilical Vein Endothelial Cells / metabolism*
  • Humans
  • Intercellular Adhesion Molecule-1 / biosynthesis*
  • Lipoproteins, LDL / pharmacology*
  • Mice, Inbred ICR
  • Monocytes / drug effects
  • Monocytes / metabolism*

Substances

  • Lipoproteins, LDL
  • oxidized low density lipoprotein
  • Intercellular Adhesion Molecule-1